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Abstract
Aims: To examine the association of patient-related factors with the effect of an in-hospital comprehensive geriatric assessment
(CGA) on hip fracture mortality.Methods: Population-based, prospective data were collected on 1425 consecutive hip fracture
patients aged 65 in a central hospital providing orthogeriatric service. Outcome was mortality at 1 month after hip fracture
associated with receiving versus not receiving CGA. Results: Of the patients receiving CGA compared to those who did not,
8.5% versus12.0% had died within 1 month of the hip fracture (P ¼ .028). In the age- and sex-adjusted Cox proportional hazards
model, CGA was associated with a decreased risk of 1-month mortality in patients aged 80 to 89 years (hazard ratio [HR] 0.46,
95% confidence interval [CI]: 0.29-0.73), females (HR: 0.57, 95% CI: 0.38-0.86), having American Society of Anesthesiologists
(ASA) score 1 to 3 (HR: 0.60, 95% CI: 0.37-0.99), taking 4 to 10 daily medications (HR: 0.59, 95% CI: 0.38-0.91), with a diagnosis of
memory disorder (HR: 0.50, 95% CI: 0.29-0.88), with an estimated glomerular filtration rate <30 mL/min/1.73m2 (HR: 0.28, 95%
CI: 0.10-0.76), or living in an assisted living accommodation (HR: 0.40, 95% CI: 0.21-0.76). Conclusion: Several modifiable and
patient-related factors were associated with decreased risk of 1-month mortality when CGA was performed during hospitali-
zation for hip fracture. Between “younger and fitter” and “oldest and frailest,” there is a large group of hip fracture patients whose
survival can be improved by in-hospital CGA.
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Introduction
Geriatric hip fractures are an increasing burden as the world
population ages. The consequences of hip fractures include
high mortality,1-3 long-term disabilities1,4 and decreased qual-
ity of life,1 and high costs of care.3
According to a consensus statement, geriatricians may pro-
vide the greatest benefit when caring for the most vulnerable
older adults,5 such as those with hip fracture. To compliment
surgical care, various models of multidisciplinary care for
patients have been developed.6 Current literature suggests the
use of a comprehensive care approach to decrease mortality in a
randomized setting,7 in a dedicated hip fracture unit8 and in
register-based studies.9 On the other hand, implementation of
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a clinical pathway with a standardized set of orders10 or includ-
ing an inpatient geriatric consultation team in the care model11
demonstrated no effect on mortality. A protocol-driven coma-
naged comprehensive care system combining a clinical path-
way and geriatric care also reduces mortality12 but not without
the involvement of a geriatrician.13
The implementation and components of orthogeriatric care
models vary,6,10making it challenging to compare different mod-
els. The background components of effective orthogeriatric care
are not verywell understoodor researched.14 Inaddition, older hip
fracture patients are a heterogeneous group15,16 and the beneficial
actions of care and rehabilitation requirements may vary, which
further complicates studies of optimal orthogeriatric models.
Moving forward, given the increasing number of hip frac-
tures, limited health-care resources, and the short supply of
geriatricians, there is a pressing need to clarify what truly is
effective orthogeriatric care. In order to increase equity and
effectiveness, targeted and tailored services may be needed.
We examined the association of patient-related factors with the
effect of an in-hospital comprehensive geriatric assessment
(CGA; Table 1) on 1-month mortality among older hip fracture
patients in an orthopedic ward during implementation of ortho-
geriatric hip fracture program (HFP).
Methods
Study Population
This is a retrospectively analyzed study of prospectively col-
lected, population-based data on 1445 consecutive hip fracture
Table 1. Summary of Current Components of Seina¨joki Central Hospital Hip Fracture Program (HFP).
Components For All Patients
Components of comprehensive geriatric assessment
(CGA; when available)
Standardized and detailed set of orders on
– Examining and imaging
– Pain management
– Fluid balance and nutritional care with supplements
– Type of anesthesia (mainly spinal)
– Surgical care for different fracture types
– Delirium prevention and management
– Oxygen therapy
– Erythrocyte transfusion thresholds of hemoglobin
– Urinary catheterization practices (removed on 1. postoperative
day)
– Mobilizing and physiotherapy
– Deep venous thrombosis prophylaxis
Preround interview by a geriatric hip fracture nurse
– Living arrangements and the level of assistance needed before
the fracture
– Mobility level and walking aids before the fracture
– Diagnosis of a memory disease or any concern of cognitive
decline (prefracture Mini-Mental Status Examination score,
if available)
– Detailed information of circumstances of the fall
– Mini-Nutritional Assessment, estimated height, weight and body
mass index
– Calcium intake (dietary and supplements) and vitamin D
supplementation
– Consent for data collection
Discharge Criteria
– Stable hemodynamics (oxygen saturation, pulse, and blood
pressure, cardiac rhythm)
– Hemoglobin > 90 g/L (>100 g/L if severe cardiac condition)
– Urinary catheter removed
– Pain under control
– Patient mobilized
– Medications updated to the outpatient file
– If treated for infection, declining C-reactive protein (CRP) and
fever
– 2nd or later postoperative day
– No discharge of a patient with immediate poor prognosis
Interdisciplinary orthogeriatric ward rounds on weekdays
– Staff: geriatrician (or a resident), orthopedic hip fracture nurse,
physiotherapist
– Encouragement and motivation of the patient
– Check-up on the adherence to standardized orders of care
protocol
– Early detection and treatment of complications
– Patient examination: orthostatic blood pressure test, oxygen
saturation, orientation, auscultation of cardiac, and pulmonary
sounds, any additional examination as needed, evaluation of
mobility
– Mobilizing the patient
– Setting the goal for rehabilitation
– Careful evaluation and adjustment of medications
– Evaluation of calcium and vitamin D intake and supplements
– Orders on examinations needed after discharge (for example, on
memory disorder and osteoporosis)
Instructions and suggestions to discharge destination
– Objectives of treatment and rehabilitation
– Physical status at discharge
– General instructions on mobilizing (including active walking
exercises, encouragement toward independency)
– Nutritional plan including supplements
– Medications plan and instructions on discontinuation of opiate pain
medications
– Planned examinations and follow-ups after discharge
– Separate discharge documents from all disciplines (geriatrician,
orthopedic, nurse, and physiotherapist)
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patients aged  65 years having their first hip fracture between
September 2007 and August 2014. The final study population
comprised 1425 hip fracture patients as 20 (1.4%) patients
declined participation in the study. Pathologic and peripros-
thetic fractures were excluded. The data were collected at Sei-
na¨joki Central Hospital, Finland, which is the only hospital that
provides acute surgical care in the Hospital District of Southern
Ostrobothnia, which has a population of 199 000.
Hip Fracture Program and Study Design
Hip fracture program was first initiated in our hospital in 2007
with the goal of improving the care of hip fracture patients in
accordance with evidence-based guidelines. First, a database
with demographic, medical, surgical, functional, social, and
outcome measures was established. Geriatrician-led interdisci-
plinary rounds began in 2008. A multidisciplinary orthogeria-
tric committee was established in 2009 and includes physicians
from geriatrics, anesthesia, and orthopedic surgery; nurses
from the orthopedic ward; and physiotherapists. Other experts
are consulted if needed. The first written HFP with a standar-
dized set of orders for hip fracture patients’ hospital stay was
delivered in 2009. The integrated care model is of shared care:
Patients are within an orthopedic ward, but the responsibility
for the care of the patient is shared between the orthopedic
surgeon and the geriatrician. The orthopedic surgeon sees the
patient daily and the geriatrician on weekdays, and both ser-
vices write their own orders. Resident physicians provide some
of the care in this model as well.
Since its initiation, the HFP has widely expanded and is
regularly updated by the orthogeriatric committee, and it has
been stabilized from a project to a permanent model of care.
The 2013 update of the HFP includes extensive instructions on
pre-, peri-, postoperative, and surgical care and CGA, dis-
charge criteria, and recommendations for postdischarge care
(Table 1). The emphasis is on detailed, individually adjusted,
and multidisciplinary care throughout and after the hospitaliza-
tion. The physicians and nurses are encouraged to focus on the
HFP through continuous education. A dedicated orthogeriatric
nurse coordinates the service in the orthopedic ward.
The HFP was developed and implemented in a real-life
setting with minimal additional resources. There are only a
few posts for geriatricians in our hospital, and, like in many
regions in Finland, occasional shortage of geriatricians has
occurred. As a consequence of this, CGA has not been per-
formed at all times. However, when a geriatrician is available,
every hip fracture patient in the orthopedic ward receives
CGA without any patient selection by exclusion or inclusion
criteria. In the present study, we compared the effect of
receiving CGA versus not receiving CGA while hospitalized
for hip fracture on 1-month mortality during implementation
of the HFP. To identify the specific patient-related factors
affecting mortality when combined with CGA, we examined
the association of baseline characteristics with the effect of
CGA on mortality. By CGA, we mean the components of care
as presented in Table 1.
Data Collection
During hospitalization, the patients’ medical records and inter-
view conducted by a nurse with the patient or a caregiver were
used. Data were collected on age, sex, fracture type, American
Society of Anesthesiology (ASA) score, on-admission serum
creatinine, number of regularly taken medications, regular or
as-needed use of hypnotic benzodiazepines and z-hypnotics
(BZD-Z; midazolam, temazepam, nitrazepam, triazolam,
zaleplon, zolpidem, and zopiclon), prefracture diagnosis of
memory disorder, prefracture mobility level and living arrange-
ments, and receiving or not receiving CGA. The Chronic
Kidney Disease Epidemiology Collaboration (CKD-EPI) equa-
tion was used to calculate estimated glomerular filtration rate
(eGFR). The results were categorized into 4 groups:  60 mL/
min/1.73 m2 (normal to mildly decreased eGFRCKD-EPI), 45 to
59 mL/min/1.73 m2 (mildly to moderately decreased
eGFRCKD-EPI), 30 to 44 mL/min/1.73 m
2 (moderately to
severely decreased eGFRCKD-EPI), and under 30 mL/min/
1.73 m2 (severely decreased eGFRCKD-EPI or kidney failure).
The dates of death were provided by the National Population
Register Center and extracted from the electronic patient files
of the hospital. There were no losses to mortality follow-up.
Statistical Analyses
The distribution of patient-related factors in case numbers and
percentages according to the CGAwere calculated. Differences
were tested using Pearson w2 test or Fisher exact test (Table 2).
One-month (1-30 days from hip fracture) mortality was ana-
lyzed by age- and sex-adjusted Cox proportional hazards mod-
els (Table 3). Age- and sex-adjusted association of receiving
versus not receiving CGA with mortality separately in each
group of the patient-related factors were performed using the
Cox proportional hazards model showing results by hazard
ratios with 95% confidence intervals (Table 4). One-month
mortality was illustrated by a survival curve (Figure 1). A
P value of <.05 was considered statistically significant. Statis-
tical analyses were performed using IBM SPSS for Windows,
version 23.0 (IBM Corp, Armonk, New York).
Ethical Consideration
The study was performed according to the 1964 Helsinki
declaration and its later amendments and approved by the
Ethics Committee of the Hospital District of South Ostroboth-
nia. Written informed consent was obtained from the partici-
pants or their caregivers.
Results
Data on 1425 hip fracture patients were available (Tables 2 and
3). The median age was 84 years (interquartile range: 78-88,
range: 65-104), and the median length of stay was 6 days
(interquartile range: 5-7, range: 1-37). Of the 1425 patients,
886 (62%) received CGA during hospitalization. Of the
patients, 36 (3%) patients died during acute hospitalization and
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140 (10%) patients within 1 month. Of the patients receiving
CGA, 8.5% died within 1 month of the hip fracture, compared
to 12.0% of the patients not receiving CGA (P ¼ .028).
Comprehensive Geriatric Assessment
The patients receiving CGA while hospitalized, compared to
those who did not, more likely had an ASA score of 1 to 3 (P¼
.002) and lived at home or in an institution (P ¼ .002). Age,
sex, number of regularly taken medications, use of BZD-Zs,
diagnosis of memory disease, eGFRCKD-EPI, prefracture mobi-
lity level, or fracture type were not significantly different
between the 2 groups (Table 2).
Age- and Sex-Adjusted 1-Month Mortality
In the age- and sex-adjusted Cox regression analysis, patients
with older age, higher ASA score, higher number of medica-
tions in regular use, having a diagnosis of memory disease,
lower eGFRCKD-EPI, living in more supported living
Table 2. Distribution of the Patient-Related Factors and Outcome Variables According to Comprehensive Geriatric Assessment.a,b
Patient-related factors
Total Comprehensive geriatric assessment
P ValueN ¼ 1425 Yes (n¼886) No (n¼539)
Age, n (%) .268
65-79 410 (29) 247 (28) 163 (30)
80-89 759 (53) 469 (53) 290 (54)
90 or over 256 (18) 170 (19) 86 (16)
Sex, n (%) .707
Women 1062 (75) 657 (74) 405 (75)
Men 363 (26) 229 (26) 134 (25)
ASA score, n (%) .002
1-3 1047 (74) 672 (76) 375 (70)
4-5 354 (25) 206 (23) 148 (28)
Number of regularly taken medications, n (%) .097
< 4 247 (17) 154 (17) 93 (17)
4-10 916 (64) 554 (63) 362 (67)
> 10 261 (18) 177 (20) 84 (16)
BZD-Z .153
No 1033 (73) 655 (74) 378 (70)
Yes 391 (27) 230 (26) 161 (30)
Diagnosis of memory disorder, n (%) .272
No 1038 (73) 635 (72) 403 (75)
Yes 379 (27) 247 (28) 132 (25)
eGFRCKD-EPI, n (%) .167
> 60 mL/min/1.73m2 821 (58) 490 (55) 331 (61)
45-59 mL/min/1.73m2 287 (29) 194 (22) 93 (17)
30-44 mL/min/1.73m2 193 (14) 125 (14) 68 (13)
< 30 mL/min/1.73m2 87 (6) 55 (6) 32 (6)
Mobility level, n (%) .070
Outdoors unassisted 743 (52) 467 (53) 276 (51)
Indoors unassisted 557 (41) 354 (40) 223 (41)
Assisted only 70 (5) 46 (5) 24 (5)
Unable to walk 25 (2) 17 (2) 8 (2)
Living arrangements, n (%) .002
Home 565 (40) 362 (41) 203 (38)
Home with organized homecare 399 (28) 235 (27) 164 (30)
Assisted living accommodation 237 (17) 136 (15) 101 (19)
Institutionalized 213 (15) 150 (17) 62 (12)
Fracture type, n (%) .545
Neck of femur 886 (62) 541 (61) 345 (64)
Intertrochanteric 458 (32) 292 (33) 166 (31)
Subtrochanteric 80 (6) 52 (6) 28 (5)
Abbreviations: ASA, American Society of Anesthesiologists; BZD-Z, hypnotic benzodiazepines and z-hypnotics (midazolam, temazepam, nitrazepam, triazolam,
zaleplon, zolpidem, and zopiclon); eGFRCKD-EPI, estimated glomerular filtration rate calculated by the Chronic Kidney Disease Epidemiology Collaboration
equation.
an ¼ 1425.
bMissing values are not shown but were tested and included in the percentages. Differences between groups were tested by Pearson w2 test or Fisher exact test.
Statistically significant P values (P < .05) are bolded.
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accommodations, having lower mobility class, and male sex
had a greater likelihood of dying within 1 month of the hip
fracture (Table 3). The patients receiving CGA were signifi-
cantly more likely to survive at 1 month after the hip fracture
than those not receiving CGA (Table 3). The survival curve is
shown in Figure 1.
Age- and Sex-Adjusted Analyses of the Effect of CGA
With Mortality in the Groups of Patient-Related Factors
In the age- and sex-adjusted Cox proportional hazards model,
CGA was significantly associated with decreased risk of 1-
month mortality in patients aged 80 to 89 years, female sex,
Table 3. Distribution and Associations of the Patient-Related Factors and Comprehensive Geriatric Assessment According to 1-month Mortality.a
Patient-related factors
1-Month Mortality
Alive, n¼1285 Deceased, n¼140 Age- and Sex Adjusted
n (%) n (%) HR (95% CI)
Age
65-79 389 (30) 21 (15) 1.00
80-89 683 (53) 76 (54) 2.21 (1.36-3.59)
90 or over 213 (17) 43 (31) 3.87 (2.28-6.55)
Sex
Women 970 (76) 92 (66) 1.00
Men 315 (25) 48 (34) 1.80 (1.26-2.45)
ASA score
1-3 983 (77) 64 (46) 1.00
4-5 290 (23) 64 (46) 2.75 (1.94-3.91)
Number of regularly taken medications
< 4 236 (18) 11 (8) 1.00
4-10 832 (65) 84 (60) 1.94 (1.03-3.63)
> 10 217 (17) 44 (32) 3.67 (1.89-7.12)
BZD-Z
No 937 (73) 96 (69) 1.00
Yes 348 (27) 43 (31) 1.09 (0.76 -1.56)
Diagnosis of memory disorder
No 952 (74) 86 (61) 1.00
Yes 330 (26) 49 (35) 1.55 (1.09-2.20)
eGFRCKD-EPI
> 60 mL/min/1.73m2 766 (60) 55 (39) 1.00
45-59 mL/min/1.73m2 252 (20) 35 (25) 1.69 (1.10-2.59)
30-44 mL/min/1.73m2 164 (13) 29 (21) 1.93 (1.22-3.07)
< 30 mL/min/1.73m2 69 (5) 18 (13) 2.99 (1.75-5.12)
Mobility level
Outdoors unassisted 718 (56) 25 (18) 1.00
Indoors unassisted 486 (38) 91 (65) 4.63 (2.95-7.28)
Assisted only 58 (5) 12 (9) 4.77 (2.38-9.59)
Unable to walk 21 (2) 4 (3) 4.04 (1.40-11.7)
Living arrangements
Home 543 (42) 22 (16) 1.00
Home with organized homecare 369 (29) 30 (21) 1.79 (1.02-3.14)
Assisted living accommodation 197 (15) 40 (29) 3.97 (2.31-6.81)
Institutionalized 169 (13) 44 (31) 5.08 (2.98-8.65)
Fracture type
Neck of femur 800 (62) 86 (61) 1.00
Intertrochanteric 410 (32) 48 (34) 0.99 (0.69 -1.41)
Subtrochanteric 74 (6) 6 (4) 0.65 (0.28 -1.49)
Comprehensive Geriatric Assessment
No 474 (37) 65 (46) 1.00
Yes 811 (63) 75 (54) 0.63 (0.45-0.87)
Abbreviations: ASA, American Society of Anesthesiologists, BZD-Z, hypnotic benzodiazepines and z-hypnotics (midazolam, temazepam, nitrazepam, triazolam,
zaleplon, zolpidem, and zopiclon), CI, confidence interval; eGFRCKD-EPI, estimated glomerular filtration rate calculated by the Chronic Kidney Disease
Epidemiology Collaboration equation; HR, hazard ratio.
an ¼ 1425.
bMissing values are not shown but were tested and included in the percentages. Associations with mortality were tested by Cox hazard regression models showing
results by HRs and 95% CIs.
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ASA score 1 to 3, using regular or as-needed BZD-Zs, having a
diagnosis of memory disease, taking 4 to 10 medications daily,
having eGFRCKD-EPI 45 to 59 mL/min/1.73, m
2 or < 30 mL/
min/1.73 m2, living in an assisted-living accommodation, or
having the fracture in the neck of the femur (Table 4).
Discussion
Based on our findings, receiving CGA while hospitalized for
hip fracture was associated with decreased 1-month mortality.
This corroborates with previous literature of HFPs having a
protective impact on short-term mortality7-9,12 Moreover, our
study revealed several potentially medically modifiable factors
and factors related to prefracture patient characteristics that
could explain the protective effect of in-hospital CGA on
short-term mortality.
In this study, patients aged 80 to 89 years benefitted from
the CGA in relation to mortality, whereas younger or older
patients did not. Older age is a well-known risk factor for
mortality after hip fracture.2,17 Younger hip fracture patients
are less frail15 and more likely to survive the hip fracture
regardless of CGA. Nonagenarians with hip fracture are high-
risk patients and are more often anemic and have more adverse
events while hospitalized.17 In our study, CGA was associated
with decreased mortality in women but not in men. Although
women suffering hip fracture are older,18 male hip fracture
patients have more chronic comorbidities,18 more severe health
conditions, and a higher risk of complications during hospita-
lization for hip fracture.19 In addition, male sex itself is a risk
factor for mortality in this patient group.2 It might be that in
women, the conditions leading to hip fracture that are more of a
concern are general frailty, including many potentially modifi-
able factors, in which case CGA can be more valuable in rela-
tion to mortality. The findings also imply that older men
require specific attention regarding hip fracture care.
According to the ASA classification, the general health of
patients with a score of 1 to 3 varies from healthy to having
severe systemic disease.20 Based on our results, the survival
potential of these patients was better when CGA was performed.
An important part of the CGA is careful and critical evalua-
tion of the patients’ medications. Our findings revealed that
patients taking 4 to 10 regular medications or using BDZ-Z
benefitted from CGA in relation to mortality. In a recent study
by Gosch et al, only 9.6% of the hip fracture patients were
taking appropriate medications.21 High number of medica-
tions22 and use of BZDs23 are associated with chronic illnesses,
which increase the importance of input from a geriatrician.
Renal insufficiency, such as multiple medication use, might
be one of the few modifiable risk factors, as the patients with
even severe renal insufficiency (eGFRCKD-EPI < 30 mL/min/
1.73m2) on admission showed improved survival if assessed by
a geriatrician. This might be partly due to a synergistic effect
with a medication evaluation because the prevalence of poten-
tially inappropriate medications in older patients with chronic
kidney disease is high.24 The protective association of CGA in
patients with renal dysfunction may also be explained by more
careful fluid therapy. Dehydration is common among hip frac-
ture patients and may increase the risk of acute renal dysfunc-
tion with a potentially poor prognosis.25
During the HFP, CGA was associated with decreased mor-
tality among patients with a prefracture-diagnosed memory
disorder. Dementia is a well-known risk factor for mortality
among hip fracture patients.2 Orthogeriatric programs not
excluding cognitively impaired patients have been successful
in reducing in-hospital7 and 1-year8 mortality. In a subgroup
analysis of hip fracture patients with dementia, the interven-
tion group experienced fewer complications and better func-
tional recovery, but the multidisciplinary intervention
program had no effect on mortality.26 Poor knowledge of the
engagement and recovery capacity of patients with dementia
affects their access to rehabilitation after hip fracture,27 and
this may also impact acute care decisions. A geriatric
approach includes individual consideration for each patient
and no denial of treatment or rehabilitation based merely on
a diagnosis of dementia. Furthermore, dementia is an inde-
pendent risk factor for iatrogenic conditions such as delir-
ium28 in hip fracture patients. An optimistic attitude
combined with professional care, including delirium preven-
tion,6 may explain some of the results of our study.
Patients living in assisted-living accommodations are too
frail to survive at home but well enough to avoid institutional
living. In our study, this patient group benefitted greatly from
CGA with regard to mortality. Community-dwelling hip frac-
ture patients are generally younger and fitter29 and therefore
may have a better prognosis regardless of the geriatrician’s
input. Patients living in long-term residential care are generally
in worse health and are thus more likely to have a poorer
outcome,30 and the geriatricians’ principal role is to ensure
quality of care toward the end of life.
In the present study, CGA was associated with improved
short-time survival when the patients had a femoral neck
Figure 1. One-month survival after hip fracture according to
comprehensive geriatric assessment by age- and sex-adjusted Cox
proportional hazard model.
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fracture. Patients experiencing other fracture types are
older,17,31 have more comorbidities,31 and a higher risk of
mortality2,31 which may determine the prognosis beyond the
effects of CGA.
One of the main strengths of the study is the prospective and
population-based design. Also, the data were collected system-
atically and almost entirely by 1 individual. In addition, cog-
nitive impairment and institutional living were not exclusion
criteria, which increases the generalizability of the study. The
study also has limitations. Due to the observational and
noninterventional nature of this real-life study, there may be
some uncertainty in the results. Toward the end of the study
time, HFP has become more comprehensive and staff more
experienced. Furthermore, there has been secular change
toward overall increase in the awareness of the needs of this
specific population. Also, although being otherwise similar, the
groups receiving versus not receiving CGA differed signifi-
cantly by the ASA scores and living arrangements. This is due
to the fact that the groups were not predetermined or counter-
balanced but were formed based on day-to-day availability of a
Table 4. Age- and Sex-Adjusted Effect of In-hospital CGA (Total n ¼ 1425, CGA n ¼ 886, no CGA n ¼ 539) on Mortality 1 Month After Hip
Fracture in the Groups of Patient-Related Factors.a
Mortality Ratio at 1 Month Comparing Groups of CGA versus non-CGA (Total Deaths
n¼140)
Patient-related factors Total (N) Deaths, n (%) HR 95% CI
Age
65-79 410 21 (5.1) 0.74 0.31-1.75
80-89 759 76 (10.0) 0.46 0.29-0.73
90 or over 256 43 (16.8) 0.98 0.52-1.85
Sex
Women 1062 92 (8.7) 0.57 0.38-0.86
Men 363 48 (13.2) 0.76 0.42-1.34
ASA
1-3 1047 64 (6.1) 0.60 0.37-0.99
4-5 354 64 (18.1) 0.86 0.53-1.42
Number of regularly taken medications
< 4 247 11 (4.5) 0.58 0.17-1.96
4-10 916 84 (9.2) 0.59 0.38-0.91
> 10 261 44 (16.9) 0.58 0.32-1.06
BZD-Z
No 1033 97 (9.4) 0.75 0.50-1.13
Yes 391 43 (11.0) 0.38 0.21-0.73
Diagnosis of memory disorder
No 1038 86 (8.3) 0.70 0.46-1.07
Yes 379 49 (12.9) 0.50 0.29-0.88
eGFRCKD-EPI
> 60 mL/min/1.73m2 821 55 (6.7) 0.73 0.43-1.24
45-59 mL/min/1.73m2 287 35 (12.2) 0.46 0.24-0.90
30-44 mL/min/1.73m2 193 29 (15.0) 0.79 0.36-1.72
< 30 mL/min/1.73m2 87 18 (20.7) 0.28 0.10-0.76
Mobility level
Outdoors unassisted 743 25 (3.4) 0.52 0.24-1.14
Indoors unassisted 557 91 (16.3) 0.75 0.49-1.14
Assisted only 70 12 (17.1) 0.77 0.24-2.42
Unable to walk 25 4 (16.0) 2.32 0.10-53.4
Living arrangements
Home 565 22 (3.9) 0.75 0.32-1.75
Home with organized homecare 399 30 (7.5) 0.81 0.39-1.69
Assisted living accommodation 237 40 (16.9) 0.40 0.21-0.76
Institutionalized 213 44 (20.7) 0.73 0.39-1.37
Fracture type
Neck of femur 886 86 (9.7) 0.44 0.29-0.68
Intertrochanteric 458 48 (10.5) 1.20 0.65-2.21
Subtrochanteric 80 6 (7.5) 0.50 0.10-2.48
Abbreviations: ASA, American Society of Anesthesiologists, BMI, body mass index; BZD-Z, hypnotic benzodiazepines and z-hypnotics (midazolam, temazepam,
nitrazepam, triazolam, zaleplon, zolpidem, and zopiclon), eGFRCKD-EPI, estimated glomerular filtration rate calculated by the Chronic Kidney Disease Epidemiology
Collaboration equation.
aStatistically significant P values (P < .10) are bolded.
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geriatrician and without preselection of patients. Further stud-
ies are warranted to examine whether the findings observed in
the present study also apply to other outcomes such as read-
missions, mobility and living arrangements, and on mortality in
longer term. We believe that a somewhat longer centralized
acute postoperative period and rehabilitation in a dedicated
orthogeriatric unit with in-hospital CGA is needed to further
improve the outcomes.
In conclusion, the observation in our study of the protec-
tive association of in-hospital CGA in patients with multiple
medications and renal insufficiency with hip fracture mor-
tality highlights the significance of comprehensive and
proactive medical assessment and interventions as funda-
mental part of acute orthogeriatric care. The orthogeriatric
approach for younger and fitter patients did not have an
effect on short-time mortality. Also, in relation to mortality,
the oldest and frailest patients with the worst prognosis did
not benefit of it either. These patients are, however, at the
core of geriatric know-how,5 and the quality of care for
those patients that are toward the end of life should be
improved by having a geriatrician in the hip fracture team.
After all, HFPs aim not only at reducing mortality but also
at improving the quality of care.10,12 Between the extremes
of low-risk and high-risk patients is a large group of patients
whose potential to survive might go unnoticed in traditional
care. Including a geriatrician and a CGA in the HFP can
actually save the lives of these patients.
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